Skip to content

In the BioHarmony Drug Report Database

Treprostinil diolamine

Orenitram, Trepulmix (treprostinil diolamine) is a small molecule pharmaceutical. Treprostinil diolamine was first approved as Orenitram on 2013-12-20. It is used to treat pulmonary hypertension in the USA. It has been approved in Europe to treat pulmonary hypertension. Orenitram's patents are valid until 2031-08-11 (FDA).
Trade Name Trepulmix
Common Name Treprostinil diolamine
Indication pulmonary hypertension
Drug Class Prostaglandins
Treprostinil diolamine
Get full access now